Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335405/
https://www.ncbi.nlm.nih.gov/pubmed/37407238
http://dx.doi.org/10.1136/jitc-2023-006814corr1
_version_ 1785070992305946624
collection PubMed
description
format Online
Article
Text
id pubmed-10335405
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103354052023-07-12 Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events J Immunother Cancer Correction BMJ Publishing Group 2023-07-05 /pmc/articles/PMC10335405/ /pubmed/37407238 http://dx.doi.org/10.1136/jitc-2023-006814corr1 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
title Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
title_full Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
title_fullStr Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
title_full_unstemmed Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
title_short Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
title_sort correction: selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335405/
https://www.ncbi.nlm.nih.gov/pubmed/37407238
http://dx.doi.org/10.1136/jitc-2023-006814corr1

Ejemplares similares